Fisher & Paykel Healthcare Board Chairman Tony Carter to retire in 2020


Fisher & Paykel Healthcare Board Chairman Tony Carter has announced his intention to retire with effect from the close of the company’s annual shareholders’ meeting in August next year. Current director Scott St John has been elected by the Board to succeed Mr Carter as chairman.
 
Mr Carter has held the role of chairman at Fisher & Paykel Healthcare since April 2012 after joining the Board in 2010. His retirement was signalled to the Board earlier this year and it is generally expected that the company’s non-executive directors will serve for a period of approximately nine years.
 
“I am delighted that Scott will succeed me, and he has the unanimous support of his fellow directors. As the chairman of our Audit & Risk Committee, Scott has been a strong leader with excellent corporate governance and commercial skills,” Mr Carter said.
 
Scott St John joined the board of Fisher & Paykel Healthcare in 2015 as an independent director. He is currently Chancellor of the University of Auckland and a director of Mercury Limited, the NEXT Foundation and Fonterra Cooperative Group Limited. He also held the role of Chief Executive Officer of First NZ Capital, now known as Jarden, from 2002 to March 2017.
 
Scott St John acknowledged the great responsibility that goes with being elected to lead the Fisher & Paykel Healthcare Board of Directors on behalf of all its stakeholders.
 
“It has been my privilege to serve on the Board of Fisher & Paykel Healthcare for the past four years, working alongside an exceptional team, led by Tony, including my fellow Board members and the management team. Fisher & Paykel Healthcare possesses a special culture and an unwavering commitment to understanding and meeting patient needs. I look forward to continuing to contribute to the development, growth and success of this remarkable company.”
 
The company is undertaking a search for another independent director to replace Mr Carter and will update the market in due course. Mr Carter’s outstanding contribution to Fisher & Paykel Healthcare will be formally acknowledged at the annual shareholders' meeting next year.
 

 

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea.  The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Ends

 

Contact

Investors:

Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073

 

Media:

Karen Knott
Senior Communications Manager
karen.knott@fphcare.co.nz
+64 (0) 21 713 911